I trade companies that have little to no revs and they're up this valuation level. Even if AMFE only has $20,000,000 revs in FY2018, which imo is lowball, it is valued less than 4X forward revenue right now... After doing the DD, does anybody doubt that this will be the lowest quarter during FY2018? Midtown alone will boost future Qs, along with Natural Stuff, the self published title, franchising, GRO3, etc
Now compare to a stock like EAPH which has zero revenues, years worth of broken promises, mass dilution and its worth about half AMFEs valuation.
Id rather buy the company that is actually PROVING growth, with minimal/highly effective dilution... the ticker with a PROVEN, profitable and highly expandable concept, which they have perfected.
AMFE is relatively cheap